Antitumor efficacy of a thrombospondin 1 mimetic CovX-body - Wikidata - wikimedia - TriplyDB

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

http://www.wikidata.org/entity/Q35116833

about

Peptide-conjugation induced conformational changes in human IgG1 observed by optimized negative-staining and individual-particle electron tomography.7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice.Original insights on thrombospondin-1-related antireceptor strategies in cancer.Thrombospondin-1-Based Antiangiogenic Therapy.Antibody Therapeutics in Oncology.Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.Chemically programmed antibodies.The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.Thrombospondin-1 is a multifaceted player in tumor progression.N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity.

P2860

Q30532713-8205815B-43AE-49D1-AB1B-22502C466DD4 Q35992488-A8277BFF-2193-435D-8D33-90E661CA187A Q36105141-4485C7C3-00DA-4B8E-B6FA-5B40AE8CA458 Q36221374-20B84860-602A-480C-82AF-522F4691DE13 Q36417463-785BDD7A-8188-4EBF-84C8-E1991A3B30AE Q36791878-7D9EA0F4-4A6C-4777-A684-EEF8698720B6 Q37613495-34617A46-C8C1-46C2-BAFE-41250E8EE0D9 Q38196060-591D30B9-3A8B-4EC8-BE4A-CF24EDE8BA51 Q45325755-BDAE5485-0347-402F-B3B5-52B4881D02E3 Q47120215-09B85EA9-D727-4103-9A73-F4DAD2DDCEBB Q53055054-BD7B91E7-11FF-40DB-8C2A-9F19001CB7C5

P2860

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

http://www.wikidata.org/entity/Q35116833

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

@ast

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

@en

type

label

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

@ast

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

@en

prefLabel

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

@ast

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

@en

P1433

Q35116833-EBBAA6BC-3869-45C0-8CC8-A402DFCA0191

P1476

Q35116833-09DD83D7-B697-43A2-A702-C85B58313CD1

P2093

Q35116833-103C31C0-12D3-44CF-BBAD-F0349C625723

Q35116833-509D9177-52DA-4AB2-AE2A-58BC35EFAB32

Q35116833-557829E5-3082-488C-882B-7830AA55BC6E

Q35116833-5EE9EE46-3661-4493-AF2F-442A8A918855

Q35116833-883B1558-8B34-4B27-BCB7-8A1B26ED58A8

Q35116833-9BC0049C-6936-4AD5-8383-02836C481102

Q35116833-AA0C9328-BF9A-4470-A939-182D9B3DC742

Q35116833-BE275802-D533-4ED8-ACFA-A794AAD41EF6

Q35116833-C3253BB2-B3FF-4A00-A7EC-ACF74FAABDF4

Q35116833-C3889A8A-CF3B-4D94-A1AC-3169D3F77069

P2860

Q35116833-0498D47D-D772-4635-9776-45F5E0B432A8

Q35116833-0CAF3BA7-5BD6-4E11-912F-F82DC21AB682

Q35116833-1743235A-B9B0-4ACC-A762-C430CFC9885A

Q35116833-1AE89313-32B6-481C-AE14-39C1A085B465

Q35116833-2D88A387-8BAA-4BB4-9C84-B77F38C3FB66

Q35116833-5482CDF8-3E0B-416D-843C-96723B9BDE13

Q35116833-8296F88C-A1C7-4EFE-84CE-659F4A24780D

Q35116833-8A6A7D5C-C457-4EE3-8674-7251BFBEDB43

Q35116833-A3A5F3E8-8E6D-49DE-AB1C-4E2CAA88D202

Q35116833-A9225DA0-3219-400D-8950-7141F1A9B541

P304

Q35116833-A1259677-8263-430B-B9AD-F36BD3488790

P31

Q35116833-714E34EF-F269-49B9-BC0B-1F3A6993686A

P356

Q35116833-29487774-F4DB-4ADE-8C37-2B0DA77B4921

P433

Q35116833-E66D9F12-D79B-4C40-8D65-DA567210B322

P478

Q35116833-9F814DE9-117E-43DB-8911-B7CC5D00C758

P577

Q35116833-57F9B562-81E5-43D7-AC32-AA72A77409A8

P5875

Q35116833-65F9B87D-42F1-4625-8C98-10F989649A60

P698

Q35116833-4B948A86-E58A-4E83-8B82-9B7DFF9195EA

P932

Q35116833-95200243-5CE3-4142-A980-8F9090BDDE18

P356

P1433

Translational Oncology

P1476

Antitumor efficacy of a thrombospondin 1 mimetic CovX-body

@en

P2093

Curt W Bradshaw

http://www.w3.org/2001/XMLSchema#string

Gary Woodnutt

http://www.w3.org/2001/XMLSchema#string

Hanhua Huang

http://www.w3.org/2001/XMLSchema#string

Janet Do

http://www.w3.org/2001/XMLSchema#string

JingYu Lai

http://www.w3.org/2001/XMLSchema#string

John D Rizzo

http://www.w3.org/2001/XMLSchema#string

Kim Johnson

http://www.w3.org/2001/XMLSchema#string

Lingna Li

http://www.w3.org/2001/XMLSchema#string

Nancy J Levin

http://www.w3.org/2001/XMLSchema#string

Rodney W Lappe

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor angiogenesis: therapeutic implications

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

Tumorigenesis and the angiogenic switch

Safety and efficacy of combining sunitinib with bevacizumab + paclitaxel/carboplatin in non-small cell lung cancer.

Evolution of potent and stable placental-growth-factor-1-targeting CovX-bodies from phage display peptide discovery.

Angiogenesis and its control in the female reproductive system.

Endogenous angiogenesis inhibitors.

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

Regulation of angiogenesis by the hemostatic system.

The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins.

P304

249-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/TLO.11136

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51536171

http://www.w3.org/2001/XMLSchema#string

P698

21804921

http://www.w3.org/2001/XMLSchema#string

P932

3140013

http://www.w3.org/2001/XMLSchema#string